Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...

Pfizer's CEO said President Donald Trump's tariffs and uncertainty are holding the company back from making "tremendous investments" in the US. In a first-quarter earnings call on Tuesday, chief ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment analysis of PFE stock.

While some key drugs from Pfizer are facing a patent cliff, ... Pfizer Is A Great Investment Over The Next Decade; Buy. Feb. 09, 2024 3:13 AM ET Pfizer Inc. (PFE) Stock PFE 74 Comments 34 Likes.

Pfizer shares currently trade at approximately $23, down 13% year-to-date and significantly below their 2021 peak of around $60. The company experienced extraordinary growth during the COVID-19 ...

Pfizer's CEO, Albert Bourla, said tariffs are preventing the company from making "tremendous investments" in the US. Leigh Vogel/Getty Images for Concordia Summit 2025-04-30T04:30:53Z ...

After the deal closes, which is expected to occur in the third quarter, Pfizer will make a $100 million equity investment in 3Sbio. To put Pfizer's deal in perspective, rival Merck & Co. Inc. (MRK ...

That drug, oxbryta, was acquired as part of Pfizer's 2022 takeover of Global Blood Therapeutics Inc. for $5.4 billion. ... Our investment management business generates asset-based fees, which ...